(Q45424364)

14 December 2017

title

Immunogenicity of peptides of measles virus origin and influence of adjuvants (English)

1 reference

14 December 2017

1 reference

1

1 reference

14 December 2017

7

Lidija Habjanec

1 reference

14 December 2017

Sanja Mateljak

2

1 reference

14 December 2017

Fabienne B Bouche

3

1 reference

14 December 2017

Mike M Pütz

4

1 reference

14 December 2017

Claude P Muller

5

1 reference

14 December 2017

Ruza Frkanec

6

1 reference

14 December 2017

Jelka Tomasić

8

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

14 December 2017

1 reference

14 December 2017

volume

24

1 reference

14 December 2017

issue

2

1 reference

14 December 2017

page(s)

185-194

1 reference

Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Protection of cattle against foot-and-mouth disease by a synthetic peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Effective synthetic peptide vaccine for foot-and-mouth disease in swine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

The effect of orientation of epitopes on the immunogenicity of chimeric synthetic peptides representing measles virus protein sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Functional fine-mapping and molecular modeling of a conserved loop epitope of the measles virus hemagglutinin protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Humoral immune responses to a protective peptide-conjugate against measles after different prime-boost regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

The rationale of a peptide-conjugate vaccine against measles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Experimental vaccines against measles in a world of changing epidemiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Neutralizing B cell response in measles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Enhanced antigenicity of a four-contact-residue epitope of the measles virus hemagglutinin protein by phage display libraries: evidence of a helical structure in the putative active site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Identification of two promiscuous T cell epitopes from tetanus toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Fine specificity of the antibody response to a synthetic peptide from the fusion protein and protection against measles virus-induced encephalitis in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Isolation and Study of the Composition of a Peptidoglycan Complex Excreted by the Biotin-Requiring Mutant of Brevibacterium divaricatum NRRL-2311 in the Presence of Penicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Isolation procedure and properties of monomer unit from lysozyme digest of peptidoglycan complex excreted into the medium by penicillin-treated Brevibacterium divaricatum mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Comparative susceptibility of a peptidoglycan monomer from Brevibacterium divaricatum and its anhydromuramyl analogue to hydrolysis with N-acetylmuramyl-L-alanine amidase. Isolation and characterization of anhydromuramyl-peptidoglycan monomer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Comparative study of the effects of peptidoglycan monomer and structurally related adamantyltripeptides on humoral immune response to ovalbumin in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Synthesis of novel adamantylacetyl derivative of peptidoglycan monomer--biological evaluation of immunomodulatory peptidoglycan monomer and respective derivatives with lipophilic substituents on amino group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Adjuvant activity of peptidoglycan monomer and its metabolic products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Influence of adjuvant-active peptidoglycan monomer on specific T cell responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Intramolecular immunodominance and intermolecular selection of H2d-restricted peptides define the same immunodominant region of the measles virus fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Differential activation of T cells by antibody-modulated processing of the flanking sequences of class II-restricted peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Heterogeneity of linear B cell epitopes of the measles virus fusion protein reacting with late convalescent sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Reversed-phase high-performance liquid chromatographic method for the determination of peptidoglycan monomers and structurally related peptides and adamantyltripeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Bystander help in primary immune responses in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

Hierarchic T-cell help to non-linked B-cell epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

7 January 2021

inferred from DOI database lookup

Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

7 January 2021

inferred from DOI database lookup

Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.057

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VACCINE.2005.07.057

1 reference

release_wjydgdjzbbggnduemhh4wtm7mm

14 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wjydgdjzbbggnduemhh4wtm7mm

24 November 2022

mapped directly with Wikidata item

1 reference